Sheaff Brock Investment Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Sheaff Brock Investment Advisors, LLC

  • $1.13 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022
SELL
$4.65 - $7.23 $115,552 - $179,665
-24,850 Closed
0 $0
Q3 2021

Nov 03, 2021
BUY
$7.41 - $10.99 $32,604 - $48,356
4,400 Added 21.52%
24,850 $190,000
Q2 2021

Aug 16, 2021
BUY
$6.35 - $10.0 $18,097 - $28,500
2,850 Added 16.19%
20,450 $198,000
Q1 2021

May 11, 2021
BUY
$7.03 - $16.51 $123,728 - $290,576
17,600 New
17,600 $146,000
Q4 2020

Feb 01, 2021
SELL
$5.76 - $11.95 $69,696 - $144,595
-12,100 Closed
0 $0
Q3 2020

Oct 30, 2020
BUY
$6.17 - $18.82 $74,657 - $227,722
12,100 New
12,100 $135,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email